For comments, suggestions
Created with Raphaël 2.1.0 01.08.2016 Filing date 28.02.2018 Validation fee payment 31.07.2018 (A1) Patent application published 06.12.2023 AGEPI application filing date 31.03.2024 (T2) Translation of the validated European patent 22.05.2025 01.08.2025 Valid until 02.08.2026 Renewal fee to be paid until 01.08.2036 Patent will expire on

Patent in force


(210)Number of the EPO application16757163
(220)Filing date of the EPO application2016.08.01
(80)EPO patent specification publication (B)EPB nr. 39/2023, 2023.09.27
(110)EPO patent number3328893
(11)Number of the documentMD 3328893 T2
(21)Number of the applicatione 2018 0567
(71)Name(s) of applicant(s), code of the countryAmgen Research (Munich) GmbH, DE;
AMGEN INC., US;
(72)Name(s) of inventor(s), code of the countryRAUM Tobias, DE;
KUFER Peter, DE;
RAU Doris, DE;
ANLAHR Jonas, DE;
BLUEMEL Claudia, DE;
HOFFMANN Patrick, DE;
NAHRWOLD Elisabeth, DE;
BAILIS Julie, US;
MUENZ Markus, DE;
BROZY Johannes, DE;
FRIEDRICH Matthias, DE;
RATTEL Benno, DE;
BOGNER Pamela, DE;
WOLF Andreas, DE;
POMPE Cornelius, DE;
(73)Name(s) of owner(s), code of the countryAMGEN Research (Munich) GmbH, DE;
AMGEN INC., US;
(54)Title of the inventionBispecific antibody constructs binding mesothelin and CD3
(13)Kind-of-document code T2
(51)International Patent Classification C07K 16/28 (2006.01.01); C07K 16/30 (2006.01.01); A61P 35/00 (2006.01.01); A61P 35/04 (2006.01.01); A61P 43/00 (2006.01.01)
(19)CountryDE
(41)Date of publication of the application2018.07.31
(49)Date of publication of the translation of the validated European patent specification2024.03.31
(30)Priority201562199939 P, 2015.07.31, US; 201662290861 P, 2016.02.03, US
(74)Patent attorney(Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova
(86)International applicationPCT/EP2016/068304, 2016.08.01
(87)International publicationWO 2017/021356, 2017.02.09
Up
/Inventions/details/3328893